Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Gursimran S. Kochhar"
Filter
Filter
Article category
Keywords
Publication year
Authors
Systematic Review and Meta-analysis
Efficacy and safety of endoscopic submucosal dissection for colorectal dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis
Talia F. Malik, Vaishnavi Sabesan, Babu P. Mohan, Asad Ur Rahman, Mohamed O. Othman, Peter V. Draganov, Gursimran S. Kochhar
Clin Endosc 2024;57(3):317-328.   Published online February 29, 2024
DOI: https://doi.org/10.5946/ce.2023.205
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: In this meta-analysis, we studied the safety and efficacy of endoscopic submucosal dissection (ESD) for colorectal dysplasia in patients with inflammatory bowel disease (IBD).
Methods
Multiple databases were searched, and studies were retrieved based on pre-specified criteria until October 2022. The outcomes assessed were resection rates, procedural complications, local recurrence, metachronous tumors, and the need for surgery after ESD in IBD. Standard meta-analysis methods were followed using the random-effects model, and I2% was used to assess heterogeneity.
Results
Twelve studies comprising 291 dysplastic lesions in 274 patients were included with a median follow-up of 25 months. The pooled en-bloc resection, R0 resection, and curative resection rates were 92.5% (95% confidence interval [CI], 87.9%–95.4%; I2=0%), 81.5% (95% CI, 72.5%–88%; I2=43%), and 48.9% (95% CI, 32.1%–65.9%; I2=87%), respectively. The local recurrence rate was 3.9% (95% CI, 2%–7.5%; I2=0%). The pooled rates of bleeding and perforation were 7.7% (95% CI, 4.5%–13%; I2=10%) and 5.3% (95% CI, 3.1%–8.9%; I2=0%), respectively. The rates of metachronous recurrence and additional surgery following ESD were 10% (95% CI, 5.2%–18.2%; I2=55%) and 13% (95% CI, 8.5%–19.3%; I2=54%), respectively.
Conclusions
ESD is safe and effective for the resection of dysplastic lesions in IBD with an excellent pooled rate of en-bloc and R0 resection.

Citations

Citations to this article as recorded by  
  • High Risk of Colorectal Cancer After High‐Grade Dysplasia in Inflammatory Bowel Disease Patients
    Monica E. W. Derks, Maarten te Groen, Lauranne A. A. P. Derikx, Iris D. Nagtegaal, Frank Hoentjen
    Alimentary Pharmacology & Therapeutics.2026; 63(5): 706.     CrossRef
  • Addition of dexmedetomidine to anesthesia regimen reduces pain level after endoscopic submucosal dissection: A systematic review and meta analysis
    Alan Gabriel Ortega-Macías, Alexis Vargas-Del Toro, Niloy Ghosh, Gicel Jacklin Aguilar, Tomas Escobar, Rafael Mancero Montalvo, Andrea Iturralde Carrillo, Vannya Marisol Ortega-Macías, Gulshan Parasher, Abu Baker Sheikh, Sergio A. Sánchez-Luna
    Journal of Clinical Anesthesia.2026; 108: 112070.     CrossRef
  • The Evolution of the Management of Dysplasia in Ulcerative Colitis
    Adrienne L. Vickers, Alessandro Fichera
    Cancers.2026; 18(7): 1165.     CrossRef
  • Management of neoplasia in inflammatory bowel disease
    Pardhu Neelam Bharath, Thomas Matthews, Pradeep Bhandari, Rupa Banerjee, Noriko Suzuki
    Frontline Gastroenterology.2026; 17(e1): e72.     CrossRef
  • Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes
    Miguel Martins, Maria Vitória Nunes, Guilherme Macedo, Mathieu Pioche, Jérémie Jacques, Sophie Geyl, Yuto Shimamura, Margarida Marques, Susana Lopes, Amadeu Cr Nunes, Isabel Faria-Ramos, Giulio Calabrese, Sandro Sferrazza, Alessandro Rimondi, Alberto Muri
    Journal of Crohn's and Colitis.2026;[Epub]     CrossRef
  • Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis
    Jesus K. Yamamoto-Furusho, Fausto D. Gutierrez-Herrera
    Cells.2025; 14(3): 162.     CrossRef
  • Colitis-Associated Dysplasia in Inflammatory Bowel Disease: Features and Endoscopic Management
    Sara C. Schiavone, Livia Biancone, Mariasofia Fiorillo, Andrea Divizia, Roberto Mancone, Benedetto Neri
    Cancers.2025; 17(5): 784.     CrossRef
  • Effect of perioperative enteral nutrition on immune and nutritional status of patients with gastric cancer after endoscopic submucosal dissection
    Shu-Yuan Zhu, Hai-Ping Shen
    World Chinese Journal of Digestology.2025; 33(4): 291.     CrossRef
  • Effect of perioperative enteral nutrition on immune and nutritional status of patients with gastric cancer after endoscopic submucosal dissection
    Shu-Yuan Zhu, Hai-Ping Shen
    World Chinese Journal of Digestology.2025; 33(4): 284.     CrossRef
  • Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFED
    Sophie Geyl, Jérémie Jacques, Alicia Anneraud, Stanislas Chaussade, Vered Abitbol, Jean Baptiste Chevaux, Laurent Peyrin-biroulet, Clara Yzet, Mathieu Pioche, Arthur Berger, David Laharie, Stéphane Koch, Sarah Leblanc, Mélanie Serrero, Marc Barthet, Jean
    Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
  • The 2024 top 10 list of endoscopy topics in medical publishing: an annual review by the American Society for Gastrointestinal Endoscopy Editorial Board
    Melissa Martinez, Michael J. Bartel, Tiffany Chua, Lara Dakhoul, Hala Fatima, Brooke Glessing, Dennis Jensen, Luis F. Lara, Brianna Shinn, Micheal Tadros, Edward Villa, John R. Saltzman
    Gastrointestinal Endoscopy.2025; 102(1): 2.     CrossRef
  • Gastrointestinal endoscopy for intestinal dysplasia and neoplasia detection and management in Crohn’s disease: when and how?
    Tommaso Pessarelli, Alessandra Piagnani, Gian Eugenio Tontini, Irene Maria Bambina Bergna, Arnaldo Amato
    Frontiers in Gastroenterology.2025;[Epub]     CrossRef
  • Advanced diagnostic and resection endoscopic techniques in managing colitis-associated neoplasia: standard of care or still utopia?
    Rossella Maresca, Giulio Calabrese, Stefano Andrea Marchitto, Tommaso Schepis, Silvia Pecere, Marcello Maida, Cristiano Spada, Sandro Sferrazza, Federico Barbaro, Olga Maria Nardone
    Best Practice & Research Clinical Gastroenterology.2025; 78: 102051.     CrossRef
  • Large colorectal lesions: Expanding the boundaries of endoscopic management
    Amit Bagrodia, Venkatesh Vaithiyam, Supraja Laguduva Mohan
    World Journal of Gastrointestinal Endoscopy.2025;[Epub]     CrossRef
  • 10,033 View
  • 201 Download
  • 13 Web of Science
  • 14 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP